home / stock / tngx / tngx news


TNGX News and Press, Tango Therapeutics Inc. From 10/09/23

Stock Information

Company Name: Tango Therapeutics Inc.
Stock Symbol: TNGX
Market: NASDAQ

Menu

TNGX TNGX Quote TNGX Short TNGX News TNGX Articles TNGX Message Board
Get TNGX Alerts

News, Short Squeeze, Breakout and More Instantly...

TNGX - Bioline Rx, Clever Leaves among healthcare movers

2023-10-09 10:00:00 ET More on Health Care Select Sector SPDR Citi turns cautious on pharmaceuticals and biotech BofA Securities: Which small cap non-earner stocks to avoid For further details see: Bioline Rx, Clever Leaves among healthcare movers

TNGX - Top 6 Momentum Stocks for the Week of September 26th

2023-09-26 07:38:47 ET DENVER, Colo., Sept 26, 2023 ( www.247marketnews.com )- The following stocks are the top performing U.S. stocks over the past week; Vaccitech (NASDAQ:VACC), Lifezone Metals (NYSE:LZM), Globus Maritime Ltd. (NASDAQ:GLBS), Siyata Mobile (NASDAQ:SYTA), ESS Tech (NYSE...

TNGX - CLNE, QDEL and SOUN are among after hour movers

2023-09-18 17:06:48 ET Gainers: Gain Therapeutics ( NASDAQ: GANX ) +7% . QuidelOrtho  ( QDEL ) +5% . ARS Pharmaceuticals ( SPRY ) +5% . ProFrac Holding  ( ACDC ) +5% . Clean Energy Fuels  ( CLNE ) +4% . L...

TNGX - Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

BOSTON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that five abstracts have been selected for poster presentations at ...

TNGX - Why Shares of Tango Therapeutics Climbed This Week

2023-09-14 17:55:00 ET Shares of Tango Therapeutics (NASDAQ: TNGX) were up 16.7% for the week as of Thursday's close, according to data provided by S&P Global Market Intelligence . The clinical-stage biotech company's stock closed at $7.06 last week, then rose as high as...

TNGX - Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG348, a Novel USP1 Inhibitor for the Treatment of BRCA1/2-mutant and Other HRD+ Cancers

BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Co...

TNGX - Tango Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

BOSTON, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics , Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Office...

TNGX - BMBL, CFLT and AMTX are among after hour movers

2023-08-30 17:09:39 ET Gainers: Okta ( OKTA ) +10% . NanoString Technologies ( NSTG ) +5% . First Interstate BancSystem ( FIBK ) +4% . Destination XL Group ( DXLG ) +4% . Avidity Biosciences ( RNA ) +4% . Losers: Five Bel...

TNGX - Tango Therapeutics Announces Updates to Its Board of Directors

BOSTON, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced changes to its Board of Directors. John Ketchum has been appointed t...

TNGX - Medicenna Announces the Appointment of Jeff Caravella as Chief Financial Officer

Jeff Caravella brings over two decades of healthcare expertise steering strategic, financial and operational functions at leading public life-science corporations Mr. Caravella’s appointment demonstrates Medicenna’s continuing commitment to establish its presence in Boston, ...

Previous 10 Next 10